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F
ordecades,one-dimensional
1HNMRspectroscopyhasbeen
a powerful technique for quantitative analysis of simple
mixtures of small molecules. Part of its suitability as an analytical
tool derives from the linear relationship between the area of a
well dispersed peak in the absorption spectrum and the concen-
tration of the associated species. A validation study of 1D
1H
quantitative NMR has established a maximum measurement
uncertainty of 1.5% with respect to the determination of molar
concentration when a precise protocol is present to control
relevant aspects of measurement procedure, data collection, and
signal processing.
1
Substantial interest exists in extending analytical NMR meth-
ods to the challenging task of performing reliable identiﬁcation
and quantiﬁcation of metabolites in biological ﬂuids (e.g., blood
and urine) and cell extracts (see references for reviews).
2,3
Quantitative analysis of most biologically relevant samples by
1D
1H NMR, however, is severely complicated by the high
degree of spectral overlap. A common experimental strategy for
reducing such overlap has been to employ proton carbon
correlated two-dimensional experiments (2D
1H 
13C HSQC)
to achieve greater spectral dispersion by exploiting the wide
chemical shift range of carbon. Use of 2D heteronuclear and
homonuclear NMR in metabolomics has risen considerably over
the past decade.
4 7 When using 2D NMR experiments for
quantiﬁcation, one must account for the fact that the cross-peak
intensity of each peak is dependent upon a range of factors not
correlatedwithspeciesconcentrationsuchasresonance-speciﬁcsignal
attenuation during the coherence transfer periods. Lewis et al.
8
reported a “fast metabolite quantiﬁcation” (FMQ) protocol to
addressthiscomplicationthatusesrapidlyacquired(12min)2D
1H 
13C HSQC experiments to estimate the molar concentra-
tion of metabolites in complex solutions from standards at
known concentrations.
A very recent approach by Hu et al.
9 directly measures 2D
1H 
13CHSQCsignalintensitiesthatarelinearlyproportionalto
sample concentration by analysis of a series of such experiments
acquired consecutively with incremented repetition times. The
attenuation factor associated with each cross-peak can be mea-
sured from a log linear regression of the integrated cross-peak
intensities and used to calculate the unattenuated intensity
at time zero. Both the FMQ
8 and extrapolated time-zero
9
approaches share the common approach of deriving sample
concentration from regression analysis of related 2D NMR
spectra.
Regardlessofwhetheroneisusing1Dand/or2Dexperiments
for quantiﬁcation, methods of data processing and analysis in
both play a vital role in implementing a reproducible and high-
throughput strategy for quantitative analysis. Lack of controls in
NMR data processing has been shown to be a key factor in the
disparity of measured results between diﬀerent operators analyz-
ing identical samples.
1 A review of quantitative metabolomics
concludes that “user skills to perform spectral deconvolution are
a serious bottleneck in the ﬁeld”.
2
Forperforminghighthroughput,reproducibleanalysisofboth
1Dand2DNMRspectra,aparametricmodelﬁttingapproachto
spectral deconvolution
10 14 would seem promising, as it can
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ABSTRACT: We have developed an algorithm called fast
maximum likelihood reconstruction (FMLR) that performs
spectral deconvolution of 1D 2D NMR spectra for the pur-
pose of accurate signal quantiﬁcation. FMLR constructs the
simplest time-domain model (e.g., the model with the fewest
number of signals and parameters) whose frequency spectrum
matches the visible regions of the spectrum obtained from identical Fourier processing of the acquired data. We describe the
application of FMLR to quantitative metabolomics and demonstrate the accuracy of the method by analysis of complex, synthetic
mixturesofmetabolitesandliverextracts. Thealgorithmdemonstratesgreateraccuracy(0.5 5.0%error)thanpeakheightanalysis
and peakintegralanalysis with greatly reduced operator intervention. FMLR has been implemented ina Java-based framework that
is available for download on multiple platforms and is interoperable with popular NMR display and processing software. Two-
dimensional
1H 
13C spectra of mixtures can be acquired with acquisition times of 15 min and analyzed by FMLR in the range of
2 5 min per spectrum to identify and quantify constituents present at concentrations of 0.2 mM or greater.4872 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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account for spectral overlap when estimating intensities and can
also make eﬀective use of a priori information, e.g., the assump-
tionofapproximatelyuniformchemicalshiftsandlinewidthsfor
corresponding signals within related spectra acquired on the
same sample. With respect to quantitative metabolomics, a
parametric approach, such as spectral deconvolution, is parti-
cularly suited to model the essential characteristics of com-
pounds contained in publicly available databases of metabolite
standards.
15,16
First applications of maximum likelihood in multiple dimen-
sions focused on pure time-domain modeling of an FID for
purposes of accurate NOESY cross-peak modeling.
11 Our earlier
work in a protein biomolecular context
13 demonstrated the
practicality of using hybrid time-domain, frequency-domain
maximum likelihood (HTFD-ML) ﬁtting methods in a series
of2D
1H 
15NHSQCrelaxationexperiments.Recently,ahybrid
approach has also been applied in 1D to spectral ﬁtting of high
resolution
1H NMR spectra in rat brain extracts given a prior
basis set of 29 compounds.
14 The focus of our work here is to
enable reproducible, larger scale quantitative analysis of complex
samples by NMR through implementation and evaluation of an
algorithm for performing spectral deconvolution of related
n-dimensional NMR spectra, more speciﬁcally, natural abun-
dance 2D
1H 
13C spectra. The algorithm described here to
perform spectral deconvolution is named “fast maximum like-
lihood reconstruction” (FMLR) not to be confused with the
same name used in a diﬀerent spectroscopic context.
17 As
explained in more detail in the Supporting Information, the
algorithm represents an evolution of the hybrid time-frequency
domain maximum likelihood (HTFD-ML) algorithm previously
reported.
12,13
FMLRhasbeenimplementedinaJava-basedprogramdubbed
“Newton” with the following design objectives:
i Robust treatment of spectral overlap: The program deals
appropriately with spectra under all three conditions of
well-dispersed, partially dispersed, or overlapped peaks.
ii Accurate modeling of line shapes: A number of common
experimental conditions (e.g., suboptimal shimming) and
processing artifacts (e.g., phase problems) can introduce
peak shapes in the frequency domain that are non-
Lorentzian.
14 A robust model ﬁtting technique relevant
to quantitative metabolomics must accurately model these
non-Lorentzian proﬁles.
iii Robust signal recognition: As is frequently the case in many
NMRstudiessuchasmetabolomics,pHtitrations,andkinetic
experiments, thefrequencypositions of corresponding signals
in related data sets may “drift”. The program recognizes
correspondingpeaks(includinghyperﬁnepatterns) inspectra
with these characteristics for the purposes of both species
identiﬁcation and accurate quantiﬁcation.
iv High throughput capability: The program supports batch
analysis on large numbers of related data sets.
v Interoperability: The program supports multiple output
ﬁle formats that are standards-based and interoperable
between popular NMR analysis programs and spread-
sheet applications.
vi Easeofdeployment:Theexecutablerequiresminimaleﬀortto
i n s t a l la n dr u no nm u l t i p l ed i ﬀerent operating systems.
We demonstrate here the application of the FMLR algorithm
implemented by Newton to the concerted analysis of related
natural abundance 2D
1H 
13C experiments collected for the
purposes of metabolite quantiﬁcation. Despite this focus, the
FMLR algorithm and the Newton application are broadly
applicable to many experiments used in metabolomics, such as
high-resolution1D
1Hand2Dhomonuclear
1H-TOCSY.FMLR
can be used to analyze any NMR experiment in which the
frequency domain response can be adequately modeled by
Fourier processing of an analytical time-domain model.
We compare the results of amplitude analysis by spectral
deconvolutiontobothpeakheightandpeakvolume analysisand
discuss situations where one may be preferable to the other. We
also discuss how the FMLR approach ﬁts into the context of a
broader goal of metabolite quantiﬁcation and identiﬁcation in
complex biological mixtures.
’METHODS
NMR Spectroscopy.All NMR experiments were collected on
VarianVNMRS 600 MHz andBruker Avance 700 MHz spectro-
meters at the National Magnetic Resonance Facility at Madison
(www.nmrfam.wisc.edu) (see Supporting Information Table 1
for details).
Preparation of Synthetic Metabolite Mixtures. Mixtures of
synthetic compounds, including relevant metabolites, were pre-
pared as described in the Supporting Information.
NMR Data Processing. The NMRPipe processing package
18
was used to perform the initial steps of NMR data processing
consisting of (i) data conversion, (ii) apozidation, (iii) zero-filling,
(iv) Fourier transformation, (v) phase correction, and (optionally)
(vi) polynomialbaseline correction. The apozidation and zero-filling
parameters in steps ii iv partially define a vector operator
_
F that can
beappliedidenticallytoboththeacquiredFIDandamodelFID.In
the FMLR algorithm, the
_
F operator converts discrete basis
functions in the time domain to discrete basis functions in the
frequency domain. The Newton software determines the
_
F
operator along each dimension (
_
F1 and
_
F2) by parsing the input
NMRPipe processing scripts (see FMLR section).
MatrixFormationandDataFormats.Tofacilitateconcerted
analysisofmultipledatasets,allofthe2Dspectrawereappended
together to form a pseudo 3D matrix where one of the matrix
dimensions is a pseudodimension that encodes the index of the
data set. The script that performs this operation, along with all
other processing scripts, is available for download (see Support-
ing Information Table 2).
Data and Software Availability. All time-domain data,
processed spectra, processing, and analysis scripts referenced in
this work are freely downloadable from the sites identified in
Supporting Information Table 2. To run the program, the only
external software required is an installed version of the Java
Runtime Environment (JRE) v1.6þ on the host machine.
General Fast Maximum Likelihood Reconstruction (FMLR).
The detailed theory and equations for applying the maximum
likelihood method to analysis of NMR data has been reported
previously.
12 This section provides an overview of fast maximum
likelihood reconstruction, an adaption of this earlier work
implemented in a modern Java-based framework, and addresses
practicalissuespertinenttoquantitativemetabolomics.Although
the examples presented here involve two-dimensional spectra,
the algorithm has been implemented such that experiments of
any dimensionality can be modeled.
Fast maximum likelihood reconstruction (FMLR) is an itera-
tive, spectral deconvolution approach as illustrated in Figure 1.4873 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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The method involves construction of a “Data Ensemble” con-
sisting of three distinct spectra:
i Data spectrum: The data spectrum is calculated from
conventional Fourier processing of the acquired FID.
The processing operations deﬁne a digital transform op-
erator along each dimension,
_
F1 and
_
F2, respectively. This
spectrumiscalculatedfromsequentialapplicationof
_
F1and
_
F2 prior to FMLR analysis.
ii Model spectrum: The model spectrum is obtained from a
sum of “cropped” signals constructed from applying the
_
F1
and
_
F2 operators to a synthetic time-domain model (see
Table 1) along each dimension. The resulting frequency-
domain signal is truncated when its proﬁle (moving away
from the peak center) drops below a noise threshold.
iii Residual spectrum: The residual spectrum is the simple
diﬀerence between the data and model spectrum. The
residual contains evidence for signals that have yet to be
modeled. The FMLR algorithm uses the residual for two
purposes: (1) to estimate the noise variance and (2) to
locate new signals to add to the current model by peak
picking at a given threshold.
For the case of multiple, related n-dimensional data sets, the
data ensemble consists of a set of three pseudo (nþ1)-dimen-
sional data, model, and residual spectra. The extra dimension is
an index that encodes a data set within the data ensemble.
The overall algorithm consists of sequential steps Steps A G
(see Figure 1) that form the main, “outer-loop” of the algorithm.
The algorithm iteratively builds the model by addition of signals
from analysis of the residual. Steps D F form an “inner loop”,
whichrepresentsoptimizationoftheparametersforaﬁxed setof
signalsderivedfromsignalsidentiﬁedinStepsBandC.Detailsof
these steps are provided in Supporting Information.
’RESULTS
Analysis of a Time-Zero
1H 
13C HSQC Series on a Simple
Synthetic Metabolite Mixture. The primary motivation for
development and application of the Newton FMLR algorithm to
spectral analysis is to obtain reproducible and accurate quantitative
information upon a set of related NMR experiments. As an initial
test case to demonstrate this capability, we chose a time-zero
1H 
13C HSQC series of a simple synthetic mixture of metabolites
at known high concentrations. Although it is not representative of
biologically relevant conditions (too few compounds and concen-
trationsgreaterthanbiologicalconcentrations),thistestcaseyieldsa
numberofcorrelationsthatprovidestrongmetricsforevaluatingthe
precision and accuracy of the results obtained from FMLR.
A synthetic metabolite mixture was prepared with concentra-
tions as given in Supporting Information Table 3. Glucose and
alanine were selected because they represent extremes with
respect to their T1 relaxation times. Glucose also exists as an
equilibriumbetweentwoanomers,whoserelativeconcentrations
can potentially be measured from accurate quantiﬁcation of the
spectra.
Asetofthree
1H 
13CHSQCexperimentswereconsecutively
acquired with incremented repetition times using the extrapo-
lated time-zero HSQC protocol.
9 The experiment is expected to
produce a set of identical cross-peaks in each of the three spectra
Figure1. Overviewoffastmaximumlikelihoodreconstruction(FMLR).
FMLR is an iterative spectral deconvolution approach. Steps A H
form the main outer loop of the algorithm. Steps D F form the inner
loop (see Supporting Information for details).
Table 1. Basis Functions and Parameters Used in FMLR
Basis Functions
a
name type expression derivative usage
sinusoid complex e
iωt ite
iωt always
damping function real e
 Rtη  t
ηe
 Rtη used except along indirect dimensions of constant time experiments
phasor complex e
iθ ie
iθ not generally used unless spectra have persistent phase artifacts
Parameters
parameter symbol variable basis function initial value constrained
frequency ω yes sinusoid from peak position no
decay rate R yes damping function from project conﬁguration or similar signal yes
decay power η no damping function assigned based on proﬁling of data sets. ﬁxed per analysis on single data set. no (ﬁxed)
phase angle θ yes phasor zero yes
aThe corresponding frequency domain functions are the time domain functions subjected to Fourier processing identical to the processed data.
Multidimensional basis functions are derived from the product of the orthogonal component basis functions along each dimension. For gradient-based
(nonlinear) optimization of the parameters, the derivative basis functions are used. The exponent η appearing in the decay rate term is a value that
modulatesthesignalbetweenaLorentzian(η=1)andGaussian(η=2)decayproﬁle.Thisvalueisadjustedtoﬁtasimilarclassofpeakshapesandisleft
constant throughout the optimization of any given data set.4874 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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that diﬀer only in their amplitudes. The signal amplitudes
(volumes) are expected to decrease geometrically with each
repetition time according to a cross-peak attenuation factor.
The spectra were processed and analyzed using the following
sequence of steps.
1 Dataconversionandprocessing:Dataconversion,apozidation,
Fourier transformation, and baseline correction (if necessary)
of the data set using NMRPipe software.
2 Pseudo-3D matrix creation: Appending the three data sets
to create a pseudo 3D matrix converted to UCSF format.
3 Projectcreation:ImportingthedatasetintoNewtonusinga
template project and data model for a series of related 2D
H-(NC) heteronuclear correlation experiments.
4 Project conﬁguration: Speciﬁcation of contour thresholds
thatdeterminetheterminationconditionofthealgorithm,i.
e. the peak picking threshold below which it will “stop”
looking for new signals in the residual.
5 Analysis: Spectral deconvolution using Newton:
a Deconvolutionisperformedusingt1as a reference data set.
b Themodelispropagatedtot2andt3withsharedfrequency
and decay rate parameters. The optimization of the shared
parameters for all three data sets is performed globally.
The spectrum resulting from the ﬁrst repetition time (t1)i s
displayed in Figure 2. The set of 28 expected
1H 
13C correlations
areshownasregionsofinterest(boxes)intheﬁgure.Theseregionsof
interest were constructed from assignment of a cluster of recon-
structed signals around “seed” peaks from an input assignment table.
Figure 3A,B displays contour and surface plots of the model
andresidualforselectedregionsofthespectra.Forthecaseofthe
methylenesignalsof3-hydroxybutyrate(HB),thedoubletisfully
resolved, but the hyperﬁne splitting of each doublet peak is only
partially visible. To accurately model the shape of each doublet,
however, Newton constructed a model containing these hyper-
ﬁne splittings.
The small size of the residual peaks relative to the original
signalsisevidentinthesurfaceplots(linearscale).Ahistogramof
that distribution is shown in Figure 4. The error analysis shows
the desired behavior of an overall distribution that is symmetric
about zero and has a small standard deviation (1.9%) relative to
the average signal height.
Thedeconvolutionwasperformedwithlimitedpriorinforma-
tion. The prior information used for spectral ﬁtting consisted
mainly of constraints on the line widths of the signals along the
acquisition dimension (see Supporting Information for explana-
tion of parameter constraints). An additional conﬁguration
parameter related to line shapes is the “power” of the decay rate
function. A value of 1 corresponds to a Lorentzian decay, and a
value of 2 corresponds to a Gaussian decay. We have found that
the application of decay powers between 1 and 2 is required for
accuratelineshapepredictiontoaccountforshimmingandother
experimental artifacts. A decay power of 1.2 was used to ﬁt this
data set. In general, relative amplitudes of peaks within the same
data set are not sensitive to the decay power used for the
experiment.
Figure2.
1H 
13CHSQCspectrumofsyntheticmetabolitemixtureI.Thecontoursareboundedbyregionsofinterest(ROIs)correspondingtothe28
expected
1H 
13C correlations in the mixture. The spectrum shown is the one acquired after the ﬁrst time increment t = 1 of the time-zero HSQC
protocol. Two more subsequent spectra were acquired at t = 2, 3. To obtain better spectral resolution in the carbon dimension, the two low-frequency
peaks of R,β-C1 glucose were folded and appear in the spectrum at high frequency (R17 and R24). The regions of interest (ROI) were exported from
Newton based on the results from FMLR and an input peak assignment table. The ROIs were imported into the rNMR metabolomics software
program,
20 which was used to create the ﬁgure.4875 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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Peak assignment tables were used to group signals obtained
from the analysis into “regions of interest” (ROIs). The quanti-
tative amplitudes reported in this section represent the sum of
signal amplitudes (peak volumes) within those regions of inter-
est. The nature of the experiment provides a number of speciﬁc
quantitative predictions which are summarized in the ensuing
sections.
Logarithmic Decrease of Amplitudes in Time-Zero HSQC
Series.The time-zero HSQC experimentis designed to produce
identical sets of spectra differing only in the ROI amplitudes that
decrease logarithmically by a cross-peak attenuation factor. The
log of the amplitude should thus produce a linear relationship
againsttheindexoftherepetitiontime.Thisexpectedcorrelation
isindeedobservedwithaverystrongcorrelation(seeSupporting
Information Figures 1A,B). These plots represent regression
curves for the regions of interest displayed in Figures 3A,B.
Predicted Molar Ratios and Relative Molar Concentra-
tionsofMetabolites.Theextrapolatedtime-zeroHSQCprotocol
is designed to produce unattenuated amplitudes that are linearly
proportional to the concentration of the underlying species. This
relationshipallowsonetopredictboththemolarratioofpeaksfrom
the same metabolite and the relative molar concentrations of each
metabolite (convertible to concentration ratios and ultimately to
absolute concentrations with an internal standard).
The molar ratio of peaks was calculated from the “ROI
volume” normalized to the number of atoms assigned to the
ROI. The “ROI volume” is the sum of the unattenuated
amplitudes obtained from analysis of all signals belonging to
that ROI. The variances in these normalized volumes are
displayed per metabolite in Figure 5A. The variances are
generally in the range of 3 5%. Larger variances are seen
(data not shown) if the spectra are analyzed independently
versus the use of the t1 data set as a reference spectrum. The
ﬁgure shows the variances obtained both from spectral decon-
volution and integration of peaks where the footprint was
speciﬁed manually for each peak. With peak integral bounds
Figure 3. Spectral deconvolution of extrapolated time-zero HSQC
1H 
13C series. The ﬁgures display contour and surface plots (Gnuplot) of the
resultsofspectraldeconvolutionof(A)themethyleneregionsof3 hydroxybutryate(BH)and(B)aregioncontainingresonancesfromBH,MES,and
glucose.Thedoubletisfullyresolved,buthyperﬁnesplittingwithinthedoubletisnot.TheNewtonmodelreconstructionsaredisplayedbothascontour
plotsandassurfaceplotssothatthemagnitudesoftheresidualscanbecompared.InFrameA,thethreesetsofspectrashowtheconcertedanalysisofthe
threeextrapolatedtime-zeroHSQCseries.Allthreeplotsintheframedisplaytheidenticalspectralregion(unitsonaxesomittedtoallowgreaterdigital
resolution for plots). A log linear regression of the amplitudes (see Supporting Information Figure 1) is used to extrapolate the cross-peak intensity.
The frequency and decay rate parameters reﬂect the global minimization of the maximum likelihood of all three data sets.4876 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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chosen manually, the variances seen in concentration estimates
forpeaks of the same metabolite (2.8%) were roughly equivalent
to the same variances measured for spectral deconvolution
(2.3%). The trend of similar variances between spectral decon-
volution and peak integration held for a range of experimental
conditions (data not shown), such as changes in the gradients or
nongradient selected versions of the experiment.
EachoftheseparateROIsprovidesanindependentmeasureof
the relative concentration of the compound associated with that
ROI.Thesumofthesepredictionsshouldyieldanoverallrelative
concentration that is more accurate (provided that the ROI is at
least partially resolved) than the estimate measured from any
individualROI.ThatresultisshowninthelightbarsofFigure5B,
which report percent error estimates for each of the metabolites
as measured by spectral deconvolution. A further independent
conﬁrmation of the accuracy of the glucose quantiﬁcation is that
the ratio of R species to all glucose species was measured to be
37%, which agrees closely with the known fraction (36.4%) of
R-glucose at equilibrium in aqueous solutions.
19 A caveat to the
concentration estimates for glucose is that its anomeric nature
and signal overlap in peaks from C3, C5, and C6 make
quantiﬁcation from these signals less accurate than that from
C1, C2, and C4. We used the latter group of peaks exclusively in
calculating glucose concentration.
Comparison of FMLR to Peak-Based Methods of Quanti-
fication. The application of FMLR to metabolomics seeks to
avoid excessive operator input and achieve greater throughput
and consistency of results. Another goal is to obtain greater
quantitativeaccuracy. To test this claim, the results of the FMLR
analysis were compared tothe similar results obtained from peak
height and peak integral analysis.
Peakheightanalysisyieldedthesamestrongcorrelationforthe
logarithmic attenuation of amplitudes in the HSQC series as did
FMLR. Both analyses produced correlation coeﬃcients g0.999.
The peak height analysis failed in this context, however, to
provide any kind of concentration measure either relative or
absolute. Alanine was grossly underestimated ( 40%) and
glucose was overestimated (þ13%). These results are easily
explained by considerations of line width. Peak intensity mea-
surements in the HSQC series fail to take line width diﬀerences
into account and, hence, yield much less accurate correlation
with concentrations.
As expected, peak integral analysis, either by manual integra-
tion or FMLR deconvolution (Figure 5A and 5B), performed
better than peak height analysis. The two approaches yielded
similar variances in concentrations based on individual peaks;
however, spectral deconvolution yielded a lower percent error in
accuracy averaged over all compounds (1.6%) than manual peak
integration (4.6%).Repetitions of theexperiment showed this as
a general trend, with manual integration yielding 2 3 times
higher errors than FMLR deconvolution for metabolite concen-
trations determined from the average of all peaks from the
compound. This result can be explained in part by the metho-
dology of peak integration, which involves operator decisions as
to where the limits of the footprints should be established when
comparingrelativepeakvolumes.AlthoughFMLRalsolimitsthe
boundary of amplitude estimation to the footprint of the region
of interest (see details in the legend to Supporting Information
Figure 2), it diﬀers from peak integration in the following
respects:
￿ The calculated amplitude from deconvolution reﬂects an
extrapolation of the basis function to inﬁnity (rather than
Figure 4. Histogram of residual peak heights for synthetic mixture I.
Shown are the ratios of the residual peak height relative to the average peak
height for the 84 = (28   3) regions of interest in the time-zero
1H 
13C
HSQCseriesofsyntheticmixtureI.Theaverageresidualheightoftheseries
was  0.3% (expected value of 0.0%). The average deviation was 1.9%.
Figure 5. Variance and accuracy of amplitude and peak integral
estimates for the extrapolated time-zero HSQC series. The ﬁgures
display (A) the percent variance per metabolite for the relative molar
concentration and (B) the percent accuracy of the molar concentration
estimates vs known concentrations. The results are shown both for
deconvolution (light bars) and manual peak integration (dark bars).
Relative molar concentrations were obtained by normalizing the “ROI
volume”bythenumberofassignedatoms.The“ROIvolume”isthesum
of the unattenuated amplitudes (obtained from deconvolution) for all
signals assigned to that ROI. The variances in these predictions among
signals of the same molecule are displayed in the bar charts (A). The
variances averaged across the metabolites were 2.3% and 2.8%, respec-
tively, for deconvolution and peak integration. The mean predicted
molar concentration of each species was calculated from the average of
all cross-peaks of the same molecule. The percent diﬀerence in these
predictions vs the known molar concentrations (determined by using
MES as the internal standard) are displayed in the bar charts (B). The
meanaccuracyacrossthemetabolitesintheﬁgurewas1.6%versus4.6%,
respectively, for deconvolution and peak integration.4877 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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just the sum of points in a deﬁned region). In the limit of
zero noise, there is thus no resultant loss of estimated signal
amplitude (amplitude underestimation) as exists with atte-
nuated peak integral calculations.
￿ Overlapping boundaries are handled more robustly with
deconvolution because the intensities in the overlapped
region are “not counted twice” (amplitude overestimation)
as is the case with peak integration. In any deconvolution
approachlikeFMLR,theoverlappedregionsaremodeledas
the sum of separate signal components estimated from the
solution to a set of linear equations.
FMQ Analysis of a Biologically Representative Synthetic
Mixture. To apply the method to data sets more representative
of conditions encountered in biological fluids, but still with
definitive quantitative predictions to test, we applied the FMLR
method to the analysis of data from our earlier study using fast
metabolite quantification (FMQ).
8 These data consisted of
rapidly collected (∼12 min) 2D
1H 
13C spectra of a set of 27
synthetic mixtures containing a basis set of 25 metabolites and 1
buffer (HEPES). Three of the mixtures served as “reference
mixtures”; they contained equimolar mixtures of all of the
metabolites at 10 mM, 5 mM, and 2 mM. The other 24 data
sets, referred to as “test mixtures”, contained a fixed concentra-
tion of 19 metabolites at 5 mM and varying concentrations of 7
other metabolites ranging from 5.5 mM to 29.1 mM. Although
each test mixture had a unique metabolite profile, the samples
were designed to group into six classes with biologically relevant
concentrations and standard deviations (see Supporting Infor-
mation Table 2 in ref 6). All concentrations were determined
gravimetrically from pure standards.
A spectrum of the 10 mM reference mixture is displayed in
Supporting Information Figure 2A. Data from the 24 test
mixturesand3referencemixtureswereprocessedconventionally
andassembledintoapseudo3Dspectrumofdimensions2048 
512   27 for global spectral analysis by FMLR. The overall
spectralreconstructiondetectedover16000signalsconsistingof
662species(aspeciesisaresonancedetectedinoneormoredata
sets). The average deviation of the residual peak height across all
signals was about 4% of the average peak height of the spectra. The
time required to perform the deconvolution on an oﬀ-the-shelf
AMD AthlonDualCoreProcessor (1 GHz) was 40min.(A single
HSQC spectrum of size 1025   512 consisting of 100 200
peaks required less than 30 s.)
From a manual assignment table consisting of peak centers of
ROIs for the 25 metabolites, the algorithm identiﬁed the set of 145
ROIs(afractionofthemareshownoverlaidonthereferencespectra
in Supporting Information Figure 2B). The experiment poses a
number of realistic challenges for signal recognition. The pattern of
resonances for a given region of interest tends to “drift” from one
data set to another. The analysis of this series was conﬁgured to
allow as much as 0.1 ppm drift in
1Ha n d1 . 0p p md r i f ti n
13Ci n
attempting to identify species (peaks of the same resonance in
diﬀerent data sets). For this analysis, the peak recognition was
carriedoutwithoutpriorinformation(i.e.,withoutknowledgeofthe
shift pattern of a particular metabolite). The peak recognition
algorithm made use of a grid correlation metric (see Methods) to
locate corresponding peaks in the related data sets.
For each ROI, the sum of the signals amplitudes assigned to
that region was used to estimate the molar concentration in each
ofthetwentyfour“testmixtures”basedonalinearregressionofthe
known molar concentration from the three reference data sets.
Thepercentaccuracywascalculatedfromthediﬀerencebetween
the predicted concentration and the known concentration nor-
malized by the known concentration. A fair amount of redun-
dancy exists inthe analysisinthat each metabolitehas more than
one ROI from which to estimate a concentration. The regions of
interest producing the best accuracy for each metabolite are
displayed in Table 2 and graphically in Figure 6. The dominant
contributiontoinaccuracyinotherROIsarosefrominconsistent
assignment of species to that ROI rather than any intrinsic error
in individual signal quantiﬁcations.
It is interesting to note that, although the results from spectral
deconvolution were on average about 38% more accurate (3%
versus 4.4%) than those from peak height measurements, this
Table 2. Accuracy of Molar Concentration Estimates in
FMLR Analysis of FMQ data
a
by deconvolution by peak height
compound % mean % SD R
2 % mean % SD R
2
alanine  0.48 2.6 0.9985  2.93 5.0 0.9999
arginine  1.64 1.9 0.9989 2.17 4.4 0.9998
asparagine 1.81 2.6 1.0000 0.82 2.3 1.0000
aspartate 0.53 2.4 0.9978  0.69 2.5 0.9994
citrulline  1.06 3.0 0.9938  2.08 3.1 0.9999
fructose  1.76 2.7 0.9999  0.92 2.6 0.9999
GABA  1.46 2.6 0.9959 2.67 4.6 1.0000
glucose  0.98 1.7 0.9980  2.18 3.7 0.9981
glutamate  0.40 2.3 0.9991 0.34 2.1 0.9986
glutamine  4.49 5.8 0.9989  6.51 8.0 0.9990
HEPES  3.43 3.7 0.9990  4.21 4.9 0.9997
histidine 1.74 5.7 0.9988 4.75 17.1 0.9999
isoleucine 0.32 1.0 0.9983  1.06 2.8 0.9990
lactate 1.83 3.0 0.9978 0.56 3.0 1.0000
leucine  0.29 1.9 1.0000  0.18 2.3 0.9995
malate  1.04 3.0 0.9990  1.27 4.0 0.9996
maltose 2.28 4.6 0.9990  5.95 7.0 0.9999
ornithine 3.26 4.8 0.9980  7.51 8.3 0.9978
proline 0.40 4.2 0.9888 1.05 3.2 1.0000
putrescine 0.83 2.3 0.9957  3.90 4.9 0.9961
serine  1.84 2.3 0.9982  0.28 2.4 0.9969
sorbitol  1.99 3.7 0.9902 0.63 1.8 0.9984
succinate 2.96 4.8 0.9997  0.38 6.1 0.9986
sucrose  0.89 2.6 0.9984  0.25 2.8 0.9998
threonine  0.78 1.1 0.9982  0.47 1.4 0.9992
valine  1.90 3.1 0.9990  0.66 3.2 0.9981
overall  0.33 3.0 0.9977  1.1 4.4 0.9991
aA set of 24 synthetic metabolite mixtures was used with relative
metabolite concentrations prepared to represent physiological condi-
tions. Details of the mixture preparation are described in the FMQ
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publication.Themixtureswereanalyzedalongwith3referencedatasets
using the FMQ protocol to measure molar concentration from linear
regression. The 27 data sets were analyzed in concerted fashion by
Newtondeconvolution.AnoverallROIamplitudewasmeasuredbytwo
means: (i) (left) sum of the amplitudes within an ROI obtained from
deconvolution and (ii) (right) height of the maximum peak in the ROI.
The mean accuracy and standard error as a percentage of the known
concentrationareshownforthetwometrics.Thevaluesforbothmetrics
correspond to regions of interest for per metabolite that yielded the
maximum accuracy (minimum error).4878 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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trend is not predicted from the linear correlations in the standards
curves, which yielded small, but consistently higher, R
2 correlation
coeﬃcients(0.999) forpeakheightsthanfordeconvolution(0.997).
Asimilartrendwasseenwithrespecttomanualpeakintegrationand
deconvolution (Figure 5) in which variance comparisons did not
show the same trends as accuracy comparisons. The evidence
presented here illustrates that greater accuracy of species quantiﬁca-
tion should not be generally inferred from observation of greater
precision. One rationalization for this observation is that organic and
biomolecules frequently produce NMR signals with complex line
shapes even when multiplets are not expected. In essence, a signal
fromamolecularspeciescanbeviewedasanensembleofresonances
(in sometreatmentsasignalismodeled asaGaussiandistributionof
Lorentzian proﬁles
14). The modulation of any resonance with
respecttoaperturbation(changeinconcentration,pH,temperature,
etc.) may not be uniform over the ensemble.
FMLR Analysis of Liver Extracts. We used 2D
1H 
13C
HSQC data collected from a series of liver extracts to evaluate
Figure6. Percentdeviationofpredictedvsknownconcentration forFMQseries.Thebarchartgraphically comparesthestandardpercentdeviationof
predictedvsknownconcentrationsforthedatadescribedinTable2.Theseriesofdarkergraybars(smallerdeviation)correspondtoamplitudeanalysis
from FMLR. The series of lighter gray bars (larger deviation) correspond to peak height analysis.
Figure 7. FMLR reconstruction of a 2D
1H 
13C spectrum of liver extract. (Left) Contour plot of a region of the
1H 
13C HSQC spectrum. (Middle)
The FMLR reconstruction of the region. (Right) The corresponding residual. Annotations on the spectrum denote the centers of signals that were
identiﬁedbyFMLR.Signalsfromglucose(A)aremuchhigherthanthosenearbyfromproline(B),andfructose(C,D,E).Thevolumeoftheobservable
residual in region A is less than 3% of the volume of the peaks.4879 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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the ability of FMLR to model the line shapes of compounds
presentinbiologicalmixtures.Figure7displaysthespectrumand
corresponding FMLR reconstructions obtained for a complex
region of the 2D
1H 
13C HSQC spectrum from a liver extract.
This region illustrates the modeling of signals from glucose
present at high concentration (∼100 mM) adjacent to signals
from fructose present at much lower concentration. The overall
visible characteristics of the residual spectra are similar to those
obtained from synthetic mixtures.
We used FMLR to analyze the relative concentrations of
metabolites from several replicate extractions from aliquots of
liver.Theconcentrationsofabout20compoundsrepresentedby
92regionsofinterestweredeterminedbytheFMQmethod.The
distribution ofvariancesofthose concentrationestimatesamong
the6samplepreparationsareshowninFigure8.Thevariancesin
the measured amplitudes (95% of the measurements are in the
3 10%errorrange)reﬂectthesamerangeofvariancesobserved
in the synthetic mixtures preparations for signals in the milli-
molar concentration range.
’CONCLUSIONS
The results show that the FMLR approach of using the Fourier
transform of a time-domain basis function as a model for spectral
deconvolution is practical for modeling line shapes in 2D
1H 
13C
correlationspectraofsolutionscontainingcompoundmixtures.The
approach yields relative concentrations of compounds present in
complex mixtures with errors in the 0.1 5% range for millimolar
concentrations. Errorsby the automated FMLR approach are lower
than those achieved by manual integration, which requires much
more operator intervention. The method is suitable for automated
analysis of the recently developed extrapolated time-zero HSQC
protocol which enables quantiﬁcation of metabolites without the
need for preparation of standards.
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The FMLR approach has been implemented in a Java applica-
tion named Newton (see Supporting Information Table 2 for
download availability) that possesses a number of characteristics
required for high throughput quantiﬁcation of multidimensional
NMR spectra: (i) ability to analyze multiple spectra in a
concerted fashion; (ii) minimal input of prior information other
than processing information; (iii) interoperability with the
popular NMRPipe
18 processing package and support of the
UCSF matrix format used by SPARKY and rNMR.
20 These
characteristics make the program also suitable for analysis of
NMR data from titrations, pressure and temperature studies,
kinetics studies, and other applications where one seeks to use a
2D heteronuclear (e.g.,
1H 
13C HSQC) or homonuclear (e.g.,
1H 
1H TOCSY) correlation experiment to probe the change in
a system with respect to a perturbation.
Results from this study obtained from spectral deconvolution
by Newton have greater accuracy than similar results from peak
height and/or peak volume measurements (Table 2, Figure 5,
and Figure 6). Although peak-based measurements in many
contexts produce equivalent (e.g., Figure 5a) or even greater
precision and linearity with respect to changes in concentration
of a species, accuracy cannot be generally estimated from this
higherprecision.Thedisparitybetweenprecisionandaccuracyis
particularly true when measuring relative amounts of diﬀerent
molecular species but may even be true for the same molecular
species as a consequence of the heterogeneous line shape of
NMR signals. This study provides evidence that “region-based”
identiﬁcations and quantiﬁcations of metabolites are superior to
“peak-based” analysis.
A limitation of the FMLR implementation is that the algo-
rithm is “spectrum-directed” rather than “metabolite-directed”.
The spectral deconvolution is currently performed without
knowledge of a speciﬁc metabolite splitting pattern. The group-
ing of spectral species into ROIs and assignment to a molecular
species is performed after the spectral deconvolution is com-
pleted. Errors in estimating the relative concentrations of metabo-
liteswithoutoperatorinterventioncanarisefrom misidentiﬁcation
of signals belonging to a given metabolite. We anticipate that the
approach can be improved by incorporating known splitting
patterns into the starting parameters used in ﬁtting the spectra.
The automated approach described here to the analysis of 2D
1H 
13C spectra is applicable to situations in which two overall
conditions can bemet: (i)the timerequired toperforma“rapid”
2D experiment (15 min) is consistent with the protocol, and (ii)
the concentrations of the compounds of interest are above a
limiting concentration. At natural abundance
13C with data
collection times of 15 min, the limiting concentrations that can
be measured to within 10% error are 0.2 mM for compounds
containing at least one resolved methyl group and 0.5 mM for
compounds containing carbon atoms with only one attached
proton.
The automated analysis of natural abundance 2D
1H 
13C
spectra also may play a potential indirect role in “targeted
proﬁling” carried out by high-resolution
1H NMR.
21 The re-
ported algorithms for spectral deconvolution using
1H spectra
rely on some means of detection and choice of metabolites to
form a so-called “basis set” of compounds. Conventionally, the
excessive overlap present in
1H NMR spectra of complex
mixtures requires that one spike a mixture with external stan-
dardstoconﬁrmthepresenceofagivenmetaboliteanditsability
to be estimated from peak-based or spectral deconvolution
methods. We suggest that the automated 2D NMR approach
described here can be used to determine the basis set to be used
for subsequent “targeted proﬁling”
21 by more rapid high-resolu-
tion
1H NMR methods.
Figure 8. Histogram of variance in ROI quantiﬁcation. Extracts were
prepared from each of 6 pieces of tissue excised from a beef liver. 2D
1H 
13C HSQCdatafrom eachextract wereanalyzedby FMLR.Ninety
tworegionsofinterestinvolvingover20metaboliteswereidentiﬁedand
quantiﬁedinthe2Dspectrumfromeachofthe6samplepreparations.A
histogram of the percentage variance of the ROI volumes shows amode
of 6% variance with a 95% range between 3 and 10%. The outlier
variances are primarily due to errors in peak correspondences (species
misassignment) rather than true variance in quantiﬁcation of signals.
The variances in these volumes are all within the range of variances
observed in the synthetic mixtures of metabolites in the millimolar
concentration range.4880 dx.doi.org/10.1021/ac200536b |Anal. Chem. 2011, 83, 4871–4880
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